Rocket Lab's expanding contracted work improves medium- and long-term revenue visibility. Synspective added 20 dedicated Electron launches for 2028-31, bringing its total to 47; backlog reached $2.4 billion after more than $1 billion in Q2 and early-Q3 awards. Space Systems broadens the business beyond launches, while Neutron's medium-lift upside still depends on reaching operational orbit. x.com 

Rocket Lab is underestimated as a launch company when it is building a broader space infrastructure business, where satellites, components, spacecraft systems and national-security demand could matter as much as launches. It just signed its largest commercial Electron deal by mission count, 20 launches for Synspective from 2028 to 2031, per Wall St Engine, pushing its launch backlog above 100 missions. x.com 

Repeated Neutron delays undermine the premium on Rocket Lab stock when execution keeps slipping. The company does not live or die by Neutron, but 50x sales was unjustified; even at 26x 2027 sales, a legitimate price suggests another 50% decline. x.com  x.com 

Rocket Lab is becoming a vertically integrated space enterprise, putting it in a different league from AST SpaceMobile. It is one of only two companies that can routinely launch to orbit, and Electron's backlog is booming after its largest commercial contract ever, 20 launches for Synspective, bringing that customer to 47. Neutron is likely in early 2027. At about twice AST's market cap, that gap should keep growing over the years even if both succeed. x.com  x.com  x.com 

Rocket Lab's Electron should gain major pricing power and margins as SpaceX winds down Falcon 9 rideshare for smaller satellites and companies. Electron is finely tuned, and Rocket Lab's largest-ever Electron deal adds 20 missions from New Zealand's LC-1 for 2028-2031, with launches booked five years out, per @itschrisray. Simultaneous launches from multiple pads worldwide should follow soon. x.com 

Rocket Lab's delayed Neutron first flight pushes out a key part of its planned launch capacity. Flight one has moved to 2027, at least 1.5 years later than the previously indicated timing; the lack of clearer guidance is frustrating. The stock could fall 50% if it breaks key support, though that downside is conditional. x.com  x.com  x.com 

Rocket Lab should deliver another great earnings report as booked contracts have piled up since an outstanding Q1. Since then it won $90M, $266M and $397M Space Force contracts, completed the Motiv Space Systems acquisition, gained Nasdaq index inclusion, was selected by NASA for three Electron launches and agreed to acquire Iridium. Those contracts won't hit revenue for a while, and a first Neutron launch in H1 2027 is the general base case. x.com  x.com 

Rocket Lab's 58% drop from its high on the Iridium deal financing is the entry for a five-year hold. The $8B Iridium acquisition adds a 66-satellite constellation with over $870M of annual revenue, turning a launch company into an end-to-end space business. Revenue grew 62% to $234M last quarter, backlog rose 137% to $2.36B with a record 90+ launches booked, Electron is 13 for 13 this year, and Neutron is targeted for the pad in Q4. x.com 

Rocket Lab's only 'moat' was Neutron, and its reported launch delay now amounts to cancellation for the investment case. The quoted report puts its inaugural launch in 2027; $2.99 is floated as a possible share price. x.com 

Rocket Lab's largest-ever launch contract and a Space Force interceptor selection add to its case for doubling or more this year, though the bigger hope is growth in space solar arrays. The contract covers five Neutron and three Electron launches; with Raytheon it was picked for the space-based interceptor program, and backlog hit a record $2.2 billion, up over 20% in a quarter. The 49% gain is mainly catch-up after strong May 8 earnings; a short-term pullback is possible but should be limited. … Show more